LEWIS JOSEPH — SEC Form 4 filings
SEC reporting owner CIK 1015747. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-25 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. (MRTX) | — | 1 | — | — | 8 |
| INSEEGO CORP. (INSG) | 10% owner | 5 | — | — | 6 |
| Tyra Biosciences, Inc. (TYRA) | — | 1 | — | — | 2 |
| iTeos Therapeutics, Inc. (ITOS) | — | 1 | — | — | 1 |
Form 4 filings — LEWIS JOSEPH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 19,654 @ $0 | EDGAR |
| 2025-09-15 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 9,427 @ $0 | EDGAR |
| 2024-11-12 | 4 | INSEEGO CORP. (INSG) jointly with Golden Harbor Ltd. | Other (J): 697,736 · Other (J): 453,528 (derivative) | EDGAR |
| 2024-10-02 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 7,655 @ $0 | EDGAR |
| 2024-07-02 | 4 | INSEEGO CORP. (INSG) | Grant/award (A): 465,385 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., Davis Aaron I. | Grant/award (A): 1,142,857 @ $17.50 | EDGAR |
| 2024-02-08 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Grant/award (A): 63,412 @ $13.01 · Grant/award (A): 705,280 (derivative) @ $13.01 | EDGAR |
| 2024-01-25 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., Dissanayake Shehan Bharatha, Fuglesang Christopher, Braslyn Ltd., Lockend Five, LLC | Disposition to issuer (D): 287,866 · Disposition to issuer (D): 3,201,440 · Disposition to issuer (D): 203,754 · Disposition to issuer (D): 3,135,966 · Disposition to issuer (D): 30,518 · Disposition to issuer (D): 332,809 (derivative) · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1015747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →